TY - JOUR AU - Beckham, Thomas H. AU - Imber, Brandon S. AU - Simone II, Charles B. PY - 2019 TI - Stereotactic body radiation therapy for oligometastatic renal cell carcinoma: improving outcomes in an otherwise radioresistant malignancy JF - Annals of Translational Medicine; Vol 7, Supplement 3 (July 30, 2019): Annals of Translational Medicine Y2 - 2019 KW - N2 - Franzese et al . recently analyzed the outcomes of patients treated at their institution with stereotactic body radiation therapy (SBRT) for oligometastatic renal cell carcinoma (RCC) (1). They reported a 2-year survival rate from SBRT of 100% and excellent local control with very few toxicities. As we place their findings into the context of overall management of metastatic RCC (mRCC), a number of points warrant discussion. UR - https://atm.amegroups.org/article/view/25681